Investors & Media Investor Relations Overview Press Releases Scientific Publications & Presentations Corporate Deck Events & Presentations Press Kit Corporate Governance Financial Info Stock Info Analyst Coverage Investor Resources Stock Information Data Provided by Refinitiv. Minimum 15 minutes delayed. Press Releases Jun 05, 2023 Intellia Therapeutics Announces Retirement of Jean-François Formela, M.D. From its Board of Directors Read More Events & Presentations Jun 12, 2023 8:00 AM EDT Intellia Therapeutics Call to Discuss Interim Clinical Data of NTLA-2002 Add to Outlook Add to Google Calendar Click Here for Webcast Jun 14, 2023 9:00 AM EDT Intellia Therapeutics 2023 Annual Meeting of Shareholders Location Virtual meeting via internet Add to Outlook Add to Google Calendar Contact IR
Stock Information Data Provided by Refinitiv. Minimum 15 minutes delayed. Press Releases Jun 05, 2023 Intellia Therapeutics Announces Retirement of Jean-François Formela, M.D. From its Board of Directors Read More Events & Presentations Jun 12, 2023 8:00 AM EDT Intellia Therapeutics Call to Discuss Interim Clinical Data of NTLA-2002 Add to Outlook Add to Google Calendar Click Here for Webcast Jun 14, 2023 9:00 AM EDT Intellia Therapeutics 2023 Annual Meeting of Shareholders Location Virtual meeting via internet Add to Outlook Add to Google Calendar
Jun 05, 2023 Intellia Therapeutics Announces Retirement of Jean-François Formela, M.D. From its Board of Directors Read More
Jun 12, 2023 8:00 AM EDT Intellia Therapeutics Call to Discuss Interim Clinical Data of NTLA-2002 Add to Outlook Add to Google Calendar Click Here for Webcast
Jun 14, 2023 9:00 AM EDT Intellia Therapeutics 2023 Annual Meeting of Shareholders Location Virtual meeting via internet Add to Outlook Add to Google Calendar